Biotron Limited (ASX:BIT)
0.0040
+0.0010 (33.33%)
Jan 30, 2026, 2:34 PM AEST
Biotron Revenue
In the fiscal year ending June 30, 2025, Biotron had annual revenue of 1.81M AUD with 10.24% growth. Biotron had revenue of -868.00 in the half year ending June 30, 2025.
Revenue
1.81M
Revenue Growth
+10.24%
P/S Ratio
3.99
Revenue / Employee
604.54K
Employees
3
Market Cap
7.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.81M | 168.51K | 10.24% |
| Jun 30, 2024 | 1.65M | 213.83K | 14.94% |
| Jun 30, 2023 | 1.43M | -127.24K | -8.16% |
| Jun 30, 2022 | 1.56M | 96.58K | 6.61% |
| Jun 30, 2021 | 1.46M | 658.92K | 82.05% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chimeric Therapeutics | 12.68M |
| Immuron | 7.29M |
| Tissue Repair | 2.63M |
| Acrux | 1.19M |
| InhaleRx | 833.90K |
| Patrys | 828.54K |
| AdAlta | 677.01K |
| Bio-Gene Technology | 524.37K |